DRI vs GSK · P/E 22, rev $13.21B vs P/E 13, $103.31B cap
Darden Restaurants Inc (DRI) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Darden Restaurants Inc (DRI) is a restaurants company listed on NYSE.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported DRI revenue for 2026-05-31 was $13.21B. Net income was $1.21B. Revenue was up 9.4% from 2025-05-25 to 2026-05-31. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
GSK does not have a complete income-statement cache yet.
DRI currently screens at market cap $24.20B and trailing P/E 22.3. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the DRI and GSK stock pages for the full models.
Not investment advice.